18.05.2023 15:25:47
|
Legend Biotech Corporation Q1 Loss Climbs
(RTTNews) - Legend Biotech Corporation (LEGN) revealed Loss for its first quarter that increased from last year
The company's earnings totaled -$112.101 million, or -$0.34 per share. This compares with -$32.289 million, or -$0.10 per share, in last year's first quarter.
The company's revenue for the quarter fell 27.4% to $36.336 million from $50.040 million last year.
Legend Biotech Corporation earnings at a glance (GAAP) :
-Earnings (Q1): -$112.101 Mln. vs. -$32.289 Mln. last year. -EPS (Q1): -$0.34 vs. -$0.10 last year. -Revenue (Q1): $36.336 Mln vs. $50.040 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Legend Biotech Corporation (spons. ADRs)mehr Nachrichten
11.11.24 |
Ausblick: Legend Biotech veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
28.10.24 |
Erste Schätzungen: Legend Biotech öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Legend Biotech Corporation (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Legend Biotech Corporation (spons. ADRs) | 37,60 | 1,08% |
|